Journals / Retina-Vitreus / 2012 / Cilt: 20 - Sayı: 1

Retinal vein occlusion in young patients: Combined MTHFR and PAI-1 mutations

Genç olgularda retinal ven oklüzyonu: MTHFR ve PAI-1 mutasyonu birlikteliği

Pages
54–58
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The presence of thrombophilic risk factors should be considered in young patients with central retinal vein occlusion.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:In this case presentation, we reported 3 young patients with retinal vein occlusion.
📊
Key Findings & Data:Methylenetetrahydrofolate reductase C677T and A1298C with plasminogen activator inhibitor-1 heterozygote gene mutations were detected in all patients on genetic analysis.
💡
Conclusion & Impact:The presence of thrombophilic risk factors should be considered in young patients with central retinal vein occlusion.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

In this case presentation, we reported 3 young patients with retinal vein occlusion. None of the patients showed any risc factors at the end of detailed systemic examinations. Methylenetetrahydrofolate reductase C677T and A1298C with plasminogen activator inhibitor-1 heterozygote gene mutations were detected in all patients on genetic analysis. The presence of thrombophilic risk factors should be considered in young patients with central retinal vein occlusion.

Özet

Bu olgu sunumunda retinal ven oklüzyonu gelişen 3 genç hasta rapor edildi. Ayrıntılı sistemik araştırmalar sonucunda hiçbir olguda bir risk faktörü saptanamadı. Yapılan genetik analizlerde, her 3 olguda da metilentetrahidrofolat redüktaz C677T ve A1298C ile plazminojen aktivatör inhibitör-1 heterozigot gen mutasyonları saptandı. Retinal ven oklüzyonlu genç hastalarda trombofilik risk faktörlerinin varlığı dikkate alınmalıdır.

🔖

Cite This Article

ERDURMUŞ, M., ÇELEBİ, S., DÜZENLİ, S. G., ÇELEBİ, H. (2012). Retinal vein occlusion in young patients: Combined MTHFR and PAI-1 mutations. Retina-Vitreus, Cilt: 20 - Sayı: 1, 54–58. https://ajindex.com/articles/307908

References (14)

  1. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-3
  2. Weisberg I, Tran P, Christensen B, et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol Genet Metab 1998;64:169-72
  3. Promthet SS, Pientong C, Ekalaksananan T, et al. Risk factors for colon cancer in Northeastern Thailand: interaction of MTHFR codon 677 and 1298 genotypes with environmental factors. J Epidemiol 2010;20:329-38
  4. Put NM van der, Gabreëls F, Stevens EM, et al. A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects? Am J Hum Genet 1998;62:1044-51
  5. Jacques PF, Bostom AG, Williams RR, et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 1996;93:7-9
  6. Ma J, Stampfer MJ, Hennekens CH, et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation. 1996;94:2410-6
  7. Tsantes AE, Nikolopoulos GK, Bagos PG, et al. The effect of the plasminogen activator inhibitor-1 4G/5G polymorphism on the thrombotic risk.Thromb Res 2008;122:736-42
  8. Rath E.Z, Frank R.N, Shin D.H, Kim C: Risk factors for retinal vein occlusions. A case-control study. Ophthalmology 1992;99:509-14
  9. Hayreh S.S, Zimmerman B, McCarthy M.J, et al. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77
  10. Wong TY, Larsen EK, Klein R, et al. Cardiovascular risk factors for retinal vein occlusion and arteriolar emboli: the Atherosclerosis Risk in Communities & Cardiovascular Health studies. Ophthalmology 2005;112:540-7
  11. Klein R, Klein BE, Moss SE, et al. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans Am Ophthalmol Soc 2000;98:133-41
  12. Chua B, Kifley A, Wong TY, et al. Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 2005;139:181-2
  13. Prisco D, Marcucci R, Bertini L, et al. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002;13:163-9
  14. Haagsma CJ, Blom HJ, van Riel PL, et al. Influence of sulphasalazine, methotrexate, and the combination of both on plasma homocysteine concentrations in patients with rheu